Cotinine as a marker for risk prediction in the Ludwigshafen Risk and Cardiovascular Health Study
Cotinine as a marker for risk prediction in the Ludwigshafen Risk and Cardiovascular Health Study
复制标题
DOI:
10.1016/j.resp.2014.10.008
复制
发表时间:
2015-04-01
影响因子:
2.3
通讯作者:
Kleber, Marcus E.
中科院分区:
文献类型:
--
作者:
Delgado, Graciela;Siekmeier, Ruediger;Kleber, Marcus E.
Background: Cotinine is one of the major metabolites of nicotine. The aim our study was to investigate cotinine as a marker for individual risk prediction in the Ludwigshafen Risk and Cardiovascular Health study.Methods: 840 samples had detectable cotinine measured using a radioimmunoassay (RIA nicotine metabolite, DPC Biermann GmbH). The distribution of risk factors across quartiles of cotinine or pack-years was analyzed by ANOVA and the association of cotinine and pack-years with mortality by Cox regression.Results: Cotinine and pack-years both showed significant association with mortality in adjusted models with HRs (95% CI) of 1.30 (1.17-1.44) and 1.26 (1.13-1.42) comparing the third to the first tertile for cotinine and pack-years, respectively. Either cotinine or pack-years or self-reported smoking increased the area-under-the-curve significantly as compared to a basic model including other risk factors.Discussion: Cotinine is a strong predictor of mortality in non-smokers as well as in smokers. As objectively measurable parameter cotinine would be preferable for risk prediction. (C) 2014 Elsevier B.V. All rights reserved.